痤疮
医学
抗生素
皮肤病科
痤疮治疗
药品
重症监护医学
养生
外科
药理学
生物
微生物学
出处
期刊:PubMed
[National Institutes of Health]
日期:2020-09-01
卷期号:13 (9): 26-32
被引量:44
摘要
Acne vulgaris is the most common dermatological disease in the United States, affecting up to 85 percent of teenagers. While the American Academy of Dermatology has established guidelines regarding acne treatment in general, the variability among acne treatments, even within a given class, prevents establishment of a straightforward regimen. For example, moderate to severe acne is generally treated with an oral antibiotic, although several options are available-both across and within antibiotic classes. The aim of this review is to report the efficacy and safety data available for commonly prescribed oral antibiotics. While there are currently no data to support superiority of one drug over another, there are substantial differences in safety profiles and brand-specific features that may make one antibiotic preferable over another.
科研通智能强力驱动
Strongly Powered by AbleSci AI